与获得对Ixodes scapularis耐药性的代谢变化相关
Yingjun Cui1, Jaqueline Matias1, Xiaotian Tang1
1Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, Room 169, 300 Cedar Street, New Haven, CT 06520-8031, USA.
Ticks and tick-borne diseases
|November 16, 2023
概括
获得的耐药性涉及到铁代谢途径的变化. 针对这种途径,特别是用基酸 (HPLA),显著增加了小鼠的死亡率,这表明了对Ixodes scapularis的新控制策略.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 代谢学 代谢学 代谢学
背景情况:
- 在多次暴露后,几内亚猪会对 Ixodes scapularis (ATR) 产生获得的耐药性.
- 背后的ATR分子机制尚未完全理解,但涉及到对唾液蛋白质的免疫反应.
- 的唾液可以改变宿主的新陈代谢,影响抵抗力的发展.
研究的目的:
- 为了研究在几内亚猪ATR的发展过程中血清代谢组的变化.
- 探索氨酸代谢途径在ATR中的作用.
- 评估准铁代谢途径以控制 Ixodes scapularis 的潜力.
主要方法:
- 在ATR发育过程中对几内亚猪血清代谢组的分析.
- 给小鼠用基酸 (HPLA),这些小鼠不会自然发展ATR.
- 给小鼠使用尼提西,一种氨酸降解抑制剂.
- 对接受治疗的小鼠暴露于 Ixodes scapularis 和死亡率的评估.
主要成果:
- 诱导xyphenyllactic acid (HPLA) 和其他类型的氨酸代谢途径成分与几内亚猪的ATR有关.
- 将HPLA给小鼠的结果是26%的 Ixodes scapularis死亡率.
- 对小鼠给予尼松导致Ixodes scapularis死亡率达到72%,而对照小鼠的死亡率为2%.
结论:
- 咬导致宿主新陈代谢中的显著变化.
- 氨酸代谢途径是宿主相互作用和获得抗性的发展的关键因素.
- 准氨酸代谢途径为控制 Ixodes scapularis 感染提供了一个有希望的策略.
相关概念视频
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


